Physician

Daniel Cary Rausch, MD

According to 2025 Medicare claims, Daniel Rausch, MD (NPI: 1649478827) practices hematology/oncology in the Lewiston-Auburn, ME market, with the plurality of this provider's patient population coming from Androscoggin, ME. This provider's primary affiliated billing organization is CENTRAL MAINE MEDICAL CENTER (NPI: 1689653487; TIN: 010211494) and primary practice location at 04240-7614. Rausch is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), participating under the MSSP model.

Rausch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 224 traditional Medicare patients, billed 626 HCPCS/CPT codes, and received $52,251 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,452 prescription claims across 250 beneficiaries totaling $4,168,113 in drug costs, led by Revlimid (Lenalidomide). DME data shows 85 claims. Open Payments data shows 36 records totaling $6,045. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $64,741 to $52,251. Similarly, Part D prescription costs have moved sharply higher in recent years, from $614,706 to $4,168,113. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $10,813 and ending at $6,340.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	326	1,082	$64,741
2016	345	1,064	$62,974
2017	352	977	$56,187
2018	348	1,038	$61,219
2019	354	1,013	$61,836
2020	305	841	$47,895
2021	293	772	$57,163
2022	292	12,713	$247,312
2023	337	120,436	$1,667,557
2024	224	626	$52,251

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	128	782	$614,706
2016	148	811	$853,609
2017	171	974	$1,701,919
2018	181	999	$2,240,989
2019	177	811	$1,932,934
2020	155	744	$1,534,019
2021	156	739	$1,109,189
2022	160	719	$1,532,006
2023	88	450	$1,327,935
2024	250	1,452	$4,168,113

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	196	$13,849
2016	N/R	28	$3,315
2017	N/R	138	$15,567
2018	N/R	170	$8,453
2019	N/R	173	$11,552
2020	N/R	157	$9,690
2021	N/R	24	$2,920
2022	N/R	12	$2,676
2023	N/R	N/R	N/R
2024	N/R	85	$9,410

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	48	48	$137
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	69	153	$109
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	36	36	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	127	276	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	74	104	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	32	840	$502,426
Xtandi	Enzalutamide	33	990	$450,159
Jakafi	Ruxolitinib Phosphate	29	860	$338,283
Lynparza	Olaparib	19	570	$297,248
Lenalidomide	Lenalidomide	24	616	$262,322

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A5057	Ostomy pouch, drainable, with extended wear barrier attached, with built in convexity, with filter, (1 piece), each	N	N/R	12	$3,389
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	16	$3,359
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	23	$1,937
J9190	Injection, fluorouracil, 500 mg	N	N/R	23	$583
A4456	Adhesive remover, wipes, any type, each	N	N/R	11	$142

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$5,809	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$236	CENTRAL MAINE MEDICAL CENTER
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Cary Rausch, MD?

Tedicare shows public-source Medicare data for Daniel Cary Rausch, MD (NPI 1649478827), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Cary Rausch, MD have ACO affiliation data?

Daniel Cary Rausch, MD is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290).

What billing organization is linked to Daniel Cary Rausch, MD?

Daniel Cary Rausch, MD is linked to CENTRAL MAINE MEDICAL CENTER (billing NPI 1689653487) in the available physician profile data.

Does Daniel Cary Rausch, MD have Open Payments data?

Daniel Cary Rausch, MD has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.